The Safety Pharmacology Society invites you to register to participate in our Diplomate in Safety Pharmacology (DSP) certification exam this fall in Washington, DC, on October 18, 2014. This initiative was started in 2013 to promote and recognize expertise in the field of Safety P
On behalf of the Society, I am pleased to announce that registration is now open for the CSRC/HESI/FDA/SPS CIPA Update Workshop on December 11, 2014. This is a follow-up meeting to the July 2013 workshop on Rechanneling the Current Cardiac Paradigm.
Study confirms the predictability of nonclinical models to humans, and show that preclinical data together with a carefully designed and monitored SAD study may provide reliable information for an early and science-based development decision.
AZD9272 and AZD2066 show lack of NMDA antagonist psychoactive effects but do share discriminative (psychoactive) effects with MTEP, a selective mGluR5 antagonist. Data suggest a specific psychoactive effect of mGluR5 antagonists.